Psychiatric Journals

Psychiatry

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Kelly T et al. - A high percentage of bipolar II and bipolar NOS patients with treatment resistant depression improved on T3. Despite the use of higher than usual doses in many of the patients, the medication was well tolerated. Augmentation with supraphysiologic doses of T3 should be considered in cases of treatment resistant bipolar depression.

Methods

Results

Related Articles

Safety and Efficacy of Quetiapine in Bipolar Depression
Annals of Pharmacotherapy, 10/13/09    Relevance Score: 67%

Mecamylamine ? a nicotinic acetylcholine receptor antagonist with potential for the treatment of neuropsychiatric disorders
Expert Opinion in Pharmacotherapy, 11/02/09    Relevance Score: 64%

Bipolar Disorder Patient Care Opportunities: Let's Answer the Call
Annals of Pharmacotherapy, 10/16/09    Relevance Score: 46%

Subgenual cingulate volumes in offspring of bipolar parents and in sporadic bipolar patients
European Archives of Psychiatry and Clinical Neuroscience, 10/13/09    Relevance Score: 46%

Sodium Load Combined with Low Doses of Exogenous Angiotensin II Upregulate Intrarenal Angiotensin II
Kidney and Blood Pressure Research, 10/08/09    Relevance Score: 46%

Today in Neuro/Psych Pharmacol...keeping you current

Risperidone long acting injection: Findings of a 2-year retrospective follow-up study
International Journal of Psychiatry in Clinical Practice, 12/02/09

Olanzapine for the Treatment of Acquired Neurogenic Stuttering
Journal of Psychiatric Practice, 12/02/09

The effect of atypical antipsychotics on pituitary gland volume in patients with first-episode psychosis: A longitudinal MRI study
Schizophrenia Research, 12/02/09


Sponsor

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Send this Summary to a Colleague

Enter email address